THYMITAQ
Phase 3- Indications
- Liver cancer
Company intelligence / Profile preview
Eximias Pharmaceutical Corporation
Berwyn, Pennsylvania, United Statesprnewswire.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Eximias Pharmaceutical Corporation was a privately held pharmaceutical company focused on the acquisition, development, and commercialization of products for the treatment of cancer and related disorders. At the time of its acquisition by YM BioSciences in May 2006, it had several novel late-stage programs in oncology and infectious disease. The company brought to YM BioSciences both cash resources ($29–30M) and an experienced management team with expertise in clinical development, regulatory affairs, marketing, manufacturing, and corporate development. After the acquisition, it became YM BioSciences USA Inc., serving as YM’s U.S. base for oncology operations[4][5][7].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- small molecules (oncology therapeutics)possibly biologics (based on oncology focus; not explicitly confirmed)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
No major external partnerships publicly disclosed before being acquired.
Beyond the preview
Go deeper on Eximias Pharmaceutical Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eximias Pharmaceutical Corporation.